Published by Iain Gilbert on 11th May 2026
(Sharecast News) - Drugmaker GSK said on Monday that it has struck an exclusive agreement with Sino Biopharmaceutical subsidiary Chia Tai Tianqing Pharmaceutical to accelerate its chronic hepatitis B treatment, bepirovirsen, in mainland China.
URL: http://www.digitallook.com/dl/news/story/35921890/...